Markets:

Overview

News

Currencies

International

Treasuries

Fulgent Genetics, Inc. - Common Stock (NQ:FLGT)

15.90 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 31, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Fulgent Genetics, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

INVESTOR ALERT: Fulgent Genetics, Inc. Investors with Substantial Losses Have Opportunity to Lead the Fulgent Genetics Class Action Lawsuit - FLGT

September 21, 2022

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm

September 21, 2022

From The Schall Law Firm

Via Business Wire

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm

September 20, 2022

From The Schall Law Firm

Via Business Wire

Why Fulgent Genetics Shares Are Trading Higher Today ↗

April 19, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022 ↗

August 25, 2022

Upgrades

Via Benzinga

Fulgent Genetics's Return On Invested Capital Insights ↗

August 22, 2022

Pulled from Benzinga Pro data, Fulgent Genetics (NASDAQ:FLGT) posted Q2 earnings of $11.10 million, an increase from Q1 of 92.77%. Sales dropped to $125.34 million, a 60.86% decrease between quarters.

Via Benzinga

Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against Fulgent Genetics, Inc. (FLGT)

August 10, 2022

From Kirby McInerney LLP

Via Business Wire

Recap: Fulgent Genetics Q4 Earnings ↗

February 23, 2022

Fulgent Genetics (NASDAQ:FLGT) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM. Here's what investors need to know about the announcement....

Via Benzinga

FULGENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Fulgent Stockholders and Encourages Investors to Contact the Firm

August 08, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Fulgent Genetics, Inc. (FLGT) on Behalf of Investors

August 08, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm

August 08, 2022

From The Schall Law Firm

Via Business Wire

FULGENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Fulgent Stockholders and Encourages Investors to Contact the Firm

August 07, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm

August 05, 2022

From The Schall Law Firm

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Fulgent Genetics, Inc. (FLGT) on Behalf of Investors

August 05, 2022

From Law Offices of Howard G. Smith

Via Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of Fulgent Genetics, Inc. (FLGT) on Behalf of Investors

August 05, 2022

From The Law Offices of Frank R. Cruz

Via Business Wire

Recap: Fulgent Genetics Q2 Earnings ↗

August 04, 2022

Fulgent Genetics (NASDAQ:FLGT) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Fulgent Genetics beat...

Via Benzinga

Fulgent Genetics Reports Second Quarter 2022 Financial Results

August 04, 2022

From Fulgent Genetics, Inc.

Via Business Wire

Fulgent Genetics Welcomes Dr. Michael Nohaile and Dr. Leonard Post to Board of Directors

August 04, 2022

From Fulgent Genetics, Inc.

Via Business Wire

Fulgent Genetics Announces Launch of PCR Based Test to Detect Monkeypox

August 04, 2022

From Fulgent Genetics, Inc.

Via Business Wire

Fulgent Genetics to Announce Second Quarter 2022 Financial Results on Thursday, August 4, 2022

July 19, 2022

From Fulgent Genetics, Inc.

Via Business Wire

Fulgent Genetics: Q1 Earnings Insights ↗

May 03, 2022

Fulgent Genetics (NASDAQ:FLGT) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Fulgent Genetics beat estimated...

Via Benzinga

Fulgent Genetics Reports First Quarter 2022 Financial Results

May 03, 2022

From Fulgent Genetics, Inc.

Via Business Wire

Fulgent Genetics Announces Promotions and Leadership Updates

May 03, 2022

From Fulgent Genetics, Inc.

Via Business Wire

Fulgent Genetics Announces Opening of New State-of-the-Art Oncology Laboratory in El Monte, California

May 03, 2022

From Fulgent Genetics, Inc.

Via Business Wire

Earnings Outlook For Fulgent Genetics ↗

May 02, 2022

Fulgent Genetics (NASDAQ:FLGT) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Fulgent...

Via Benzinga

Fulgent Genetics Agrees to Acquire Inform Diagnostics and Provides Preliminary First Quarter Revenue Results

April 18, 2022

From Fulgent Genetics, Inc.

Via Business Wire

Fulgent Genetics to Announce First Quarter 2022 Financial Results on Tuesday, May 3, 2022

April 18, 2022

From Fulgent Genetics, Inc.

Via Business Wire

These Are Ten Small Cap Stocks With Strong Buy Recommendations ↗

March 27, 2022

One can reduce some risk by taking into account analyst recommendations. Stocks with strong buy recommendations are more likely to perform better than others. Let’s take a look at ten small cap stocks...

Via Talk Markets

The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company ↗

February 24, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (...

Via Benzinga

Fulgent Genetics Announces Strategic Investment in Spatial Genomics

February 23, 2022

From Fulgent Genetics, Inc.

Via Business Wire

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.